Companies Lucid Diagnostics Inc.
Lucid Diagnostics (LUCD): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Lucid Diagnostics Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask; press Download and a copy goes to your email too. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $300,000FY2023
- $712,000FY2024
- $897,000FY2025
CEO total pay was $897,000 in fiscal 2025, up from $712,000 in fiscal 2024.
FY2025: salary $300,000 · bonus $150,000 · stock awards $447,000 · option awards $0
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Lishan Aklog | $300,000 | $150,000 | $447,000 | $0 | $0 | $0 | $0 | $897,000 |
| Chairman of the Board and Chief Executive Officer | ||||||||
| Shaun O’Neil | 300,000 | 75,000 | 447,000 | 0 | 0 | 0 | 0 | 822,000 |
| President and Chief Operating Officer | ||||||||
| Michael Gordon | 250,000 | 62,500 | 447,000 | 0 | 0 | 0 | 0 | 759,500 |
| General Counsel and Corporate Secretary | ||||||||
| Dennis McGrath | 225,000 | 78,750 | 447,000 | 0 | 0 | 0 | 0 | 750,750 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Lishan Aklog | $897,000 | $712,000 | $300,000 | ↑ +185,000 |
| Shaun O’Neil | 822,000 | 712,000 | 162,500 | ↑ +110,000 |
| Michael Gordon | 759,500 | 662,000 | 250,000 | ↑ +97,500 |
| Dennis McGrath | 750,750 | 637,000 | 225,000 | ↑ +113,750 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company believes granting equity incentive compensation to its named executive officers provides a strong link to its long-term performance, creates an ownership culture, and aligns the interests of its named executive officers with the stockholders of the Company. The compensation committee strives to create incentives that encourage behavior consistent with the Company’s business strategy, without encouraging undue risk-taking.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Michael Gordon | RSU | 700,000 | — | $763,000 |
| Shaun O’Neil | RSU | 820,000 | — | 893,800 |
| Lishan Aklog | RSU | 1,324,400 | — | 1,443,596 |
| Dennis McGrath | RSU | 1,324,400 | — | 1,443,596 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Ronald M. SparksIndependent · Audit · Compensation · Nominating and Corporate Governance · Technology, Compliance and Quality | $110,000 | $168,072 | $0 | — | $0 | $278,072 |
| Jacque J. Sokolov, M.DAudit · Compensation | 100,000 | 168,072 | 0 | — | 0 | 268,072 |
| Dennis A. MatheisAudit · Compensation | 85,500 | 168,072 | 0 | — | 0 | 253,572 |
| Debra J. WhiteIndependent · Audit · Nominating and Corporate Governance | 80,000 | 168,072 | 0 | — | 0 | 248,072 |
| James L. Cox, M.DNominating and Corporate Governance | 70,000 | 168,072 | 0 | — | 0 | 238,072 |
| Stanley N. LapidusTechnology, Compliance and Quality | 62,500 | 168,072 | 0 | — | 0 | 230,572 |
| John R. PalumboAudit · Compensation | 21,087 | 0 | 139,750 | — | 0 | 160,837 |
Board fee structure and ownership guideline
| Annual cash retainer | $50,000 |
|---|---|
| Annual equity retainer | $150,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 27,500 / 18,000 / 12,500 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $529,087 |
| Equity awards (grant-date value) | $1,008,432 |
| All other compensation | $0 |
| Total cost of the board | $1,537,519 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Lucid Diagnostics as a peer
Companies that benchmark against LUCD
1 company names LUCD as a compensation peer
- SERA PROGNOSTICS, INC.SERAFY2025
Each company listed discloses LUCD in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named LUCD in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Lucid Diagnostics Inc. | 2025 | Lishan Aklog | $300,000 | $447,000 | $0 | $0 | $897,000 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-24 | — | — | — | — | — |
| 2025 | 2025-06-18 | — | — | — | — | — |
| 2024 | 2024-07-23 | — | — | — | — | — |
| 2023 | 2023-06-21 | — | — | — | — | — |
| 2022 | 2022-06-21 | — | — | — | — | — |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-06-24 | —a |
| 2025 | 2025-06-18 | —b |
| 2024 | 2024-07-23 | —c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Dennis A. Matheis | Director | 2026-05-20 | A | 245,000 | $1 | $245,270 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (18 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Lishan Aklog. DEF 14A, filed 2026-04-30. Section “Executive Compensation” · page 32. As printed: 897,000. View filing ↗
- Section 01, Shaun O’Neil. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 822,000. View filing ↗
- Section 01, Michael Gordon. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 759,500. View filing ↗
- Section 01, Dennis McGrath. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 750,750. View filing ↗
- Section 08, Ronald M. Sparks. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 278,072. View filing ↗
- Section 08, Jacque J. Sokolov, M.D. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 268,072. View filing ↗
- Section 08, Dennis A. Matheis. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 253,572. View filing ↗
- Section 08, Debra J. White. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 248,072. View filing ↗
- Section 08, James L. Cox, M.D. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 238,072. View filing ↗
- Section 08, Stanley N. Lapidus. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 230,572. View filing ↗
- Section 08, John R. Palumbo. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 160,837. View filing ↗
- Section 02, Dennis A. Matheis 2026-05-20. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-06-24. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-06-18. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-07-24. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 529,087 + equity 1,008,432 + all other 0 = 1,537,519, summed across the director compensation table rows.
- Lucid Diagnostics Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in Lucid Diagnostics Inc.'s own proxy. As printed: 897,000. View filing ↗